title: Mucocutaneous lichen planus with esophageal involvement: successful treatment with an anti-CD20 monoclonal antibody.
authors.affiliation: Service de Dermatologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland. laurent.parmentier@chu-lyon.fr
authors.forename: Laurent
authors.initials: L
authors.lastname: Parmentier
authors.forename: Blaise-Alain
authors.initials: BA
authors.lastname: Bron
authors.forename: Christa
authors.initials: C
authors.lastname: Prins
authors.forename: Jacky
authors.initials: J
authors.lastname: Samson
authors.forename: Isabelle
authors.initials: I
authors.lastname: Masouyé
authors.forename: Luca
authors.initials: L
authors.lastname: Borradori
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D001707:Biopsy, Needle; D003680:Deglutition Disorders / Q000175:diagnosis / Q000209:etiology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004935:Esophageal Diseases / Q000175:diagnosis / Q000188:drug therapy*; D004945:Esophagoscopy / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D008010:Lichen Planus / Q000175:diagnosis / Q000188:drug therapy*; D008875:Middle Aged; D000069283:Rituximab; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab